Zydus Cadila files investigational new drug application for COVID-19 treatment

Drug firm Zydus Cadila on Tuesday said it has filed the investigational new drug (IND) application for ZYIL1, positioned for management of critically ill COVID-19 patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3jRJoYh
via IFTTT